Myrtelle shared clinical trial updates and future directions for Oligodendrocyte targeting AAVs at the 27th Annual Meeting of the ASGCT.
Where Glioma Research Is Actually Moving Forward Glioblastoma (GBM) is the most common and most…
Where Glioma Research Is Actually Moving Forward Glioblastoma (GBM) is the most common and most…